ISO/TS 19218 WHO Informal Consultation on Nomenclatures for Medical Devices March 23-24, 2011 Leighton Hansel Convener ISO/TC210 WG3 Symbols and Nomenclature.

Slides:



Advertisements
Similar presentations
1ISO policy on global relevance MAS/PGR Jannuary 2006 ISO Policy on global relevance.
Advertisements

You have been given a mission and a code. Use the code to complete the mission and you will save the world from obliteration…
Pharmacology and the Nursing Process in LPN Practice
Kapitel 21 Astronomie Autor: Bennett et al. Galaxienentwicklung Kapitel 21 Galaxienentwicklung © Pearson Studium 2010 Folie: 1.
Copyright © 2011, Elsevier Inc. All rights reserved. Chapter 5 Author: Julia Richards and R. Scott Hawley.
1 Copyright © 2010, Elsevier Inc. All rights Reserved Fig 2.1 Chapter 2.
By D. Fisher Geometric Transformations. Reflection, Rotation, or Translation 1.
September 2013 ASTM Officers Training Workshop September 2013 ASTM Officers Training Workshop Membership & Roster Maintenance September 2013 ASTM Officers.
FpML REPORTING WORKING GROUP Copyright © 2010 International Swaps and Derivatives Association, Inc. JANUARY 2010 – SLIDE 1 ISDA FpML Update Brian Lynn.
Implementation of a Validated Statistical Computing Environment Presented by Jeff Schumack, Associate Director – Drug Development Information September.
Business Transaction Management Software for Application Coordination 1 Business Processes and Coordination.
The National Standards and Quality System Jean-Louis Racine The World Bank Cambridge, England April 19, 2007 Knowledge Economy Forum VI Technology Acquisition.
Toulouse, May 2011, Slide 1 20 x 20. Toulouse, May 2011, Slide 2 20 x 20.
The Implementation Structure DG AGRI, October 2005
GMDN Global Medical Device Nomenclature
WHO Good Distribution Practices for Pharmaceutical Products
WHO Prequalification of Diagnostics WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies 29 Oct – 2 November, Geneva Anita Sands Diagnostics.
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Jeopardy Q 1 Q 6 Q 11 Q 16 Q 21 Q 2 Q 7 Q 12 Q 17 Q 22 Q 3 Q 8 Q 13
Title Subtitle.
Training for Teachers and Specialists
0 - 0.
ALGEBRAIC EXPRESSIONS
DIVIDING INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
SUBTRACTING INTEGERS 1. CHANGE THE SUBTRACTION SIGN TO ADDITION
MULT. INTEGERS 1. IF THE SIGNS ARE THE SAME THE ANSWER IS POSITIVE 2. IF THE SIGNS ARE DIFFERENT THE ANSWER IS NEGATIVE.
Addition Facts
Year 6 mental test 5 second questions
ZMQS ZMQS
Richmond House, Liverpool (1) 26 th January 2004.
Slide 1 Copyright © 2004 Glenna R. Shaw & FTC Publishing Background Courtesy of Awesome BackgroundsAwesome BackgroundsDeliberation!Deliberation!
10/20/ The Pharmaceutical Industry and Their Influence on Pain Management in the ED J. David Haddox, DDS, MD VP, Risk Management & Health Policy.
Comparison GHTF/SG5/N5:2012 vs. MEDDEV 2.7/3:2010
ABC Technology Project
EU Market Situation for Eggs and Poultry Management Committee 21 June 2012.
Why is your new product launch behind schedule?
World Health Organization
© S Haughton more than 3?
© Charles van Marrewijk, An Introduction to Geographical Economics Brakman, Garretsen, and Van Marrewijk.
© Charles van Marrewijk, An Introduction to Geographical Economics Brakman, Garretsen, and Van Marrewijk.
© Charles van Marrewijk, An Introduction to Geographical Economics Brakman, Garretsen, and Van Marrewijk.
CEN, Avenue Marnix Brussels, Belgium  The CEN range of deliverables.
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
Squares and Square Root WALK. Solve each problem REVIEW:
© 2012 National Heart Foundation of Australia. Slide 2.
Past Tense Probe. Past Tense Probe Past Tense Probe – Practice 1.
آزمایشگاه مهندسی نرم افزار
Chapter 5 Test Review Sections 5-1 through 5-4.
GG Consulting, LLC I-SUITE. Source: TEA SHARS Frequently asked questions 2.
Timeline/Issues January to July 2012 FEPA Mid Year Work Session 2012.
1 First EMRAS II Technical Meeting IAEA Headquarters, Vienna, 19–23 January 2009.
Compliance Assurance Process (CAP) Permanency
Addition 1’s to 20.
25 seconds left…...
Test B, 100 Subtraction Facts
Week 1.
We will resume in: 25 Minutes.
Non Road Mobile Machinery Engines Global Technical Regulation Complete Informal Document NRMM WG Informal document No. GRPE (57th.
1 Unit 1 Kinematics Chapter 1 Day
PSSA Preparation.
Immunobiology: The Immune System in Health & Disease Sixth Edition
1 PART 1 ILLUSTRATION OF DOCUMENTS  Brief introduction to the documents contained in the envelope  Detailed clarification of the documents content.
How Cells Obtain Energy from Food
Immunobiology: The Immune System in Health & Disease Sixth Edition
Revision of WIPO Standard ST.14 Committee on WIPO Standards, third session Geneva 15 – 19 April 2013 Anna Graschenkova Standards Section.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
Presentation transcript:

ISO/TS 19218 WHO Informal Consultation on Nomenclatures for Medical Devices March 23-24, 2011 Leighton Hansel Convener ISO/TC210 WG3 Symbols and Nomenclature for Medical Devices Director, Regulatory Affairs Abbott Quality and Regulatory Abbott Laboratories

1999 Proposed NWIP Standard for coding device failures suggested to ISO/TC 210 WG 3, Symbols and Nomenclature for Medical Devices by FDA/GHTF SG2 To support adverse event information exchange between regulatory authorities Manufacturer submissions of adverse event reports to regulatory authorities. Could also be used by end users Excluded patient outcomes For post market events, not for clinical studies

History of TS 19218 NWIP approved 2000 Background information gathered early 2002 ISO/TC 210 WG 3, concluded that work should result in a Technical Specification WD Prepared mid 2002 Consulted with GHTF SG2 in 2003 DTS Voted on early 2004 and revised As result of preparing DTS2, WG3 concluded NWIP for introduction of hierarchical structure should be proposed DTS 2 Voted on, revised and published as TS 19218:2005 NWIP for hierarchical structure approved 2005 WG3 Decided to split into 2 Documents, Event Type Codes(-1) and Evaluation Codes(-2) 19218-1 Event Type Codes submitted for publication 2010 Amendment 1 to 19218-1 coding examples under development WG3 will review draft of 10218-2 in 2011 with publication in 2012

Initial Version of TS19218 Development based on two documents FDA Coding Evaluation Report – An Evaluation of the Coding System for Device Problems and Patient Effects Used to Report Adverse Medical Device Events to the FDA MedWatch Program Report on Medical Device Fault Conditions (NKKN, Haukeland University Hospital)

Revised TS 19218 WG revised to consist of event types and cause codes Definitions The adverse event type code characterizes the observed use/malfunction/failure of the medical device at the time the event occurred. The adverse event cause code characterizes the latest conclusions of a cause analysis of the adverse event. Number of codes As Issued (2005) – 22 Type and 46 Cause

Device vs. Drug Report Numbers

EU – Device Reports

Code Development/Use Considerations Use of codes Regulatory authorities Level of detail related to size of regulatory authority and number of adverse event reports received Level of detail for data exchange Manufacturers “Buckets” Supplemental coding IT applications as support tools Maintenance

Example FDA Hierarchical Structure

Global Vision of Harmonized Event Type Codes Manufacturer Codes (XXX) FDA Codes (476) TS 19218 Level Two Codes (82) TS 19218 Level One Codes (20)

19218-1 Event Type Codes Level 1

Example of Event Type Codes TS19218-1

Examples being developed for 19218-1

19218-2 vs. 19218:2005

Portion of Draft TS19218-2

Portion of Draft TS19218-2

Level 1 Terms – TS19218-2